All the latest about our company
New Publication Highlights Enhancement of attyloid’s sFIDA Technology Through Internal Quality Control Standards
May 10, 2023attyloid's recent publication has outlined the establishment of an internal quality control (IQC) standard aimed at improving the robustness of ...
Meet us at Neuro 4D
April 21, 2023The Neuro4D conference takes place in Mainz, Germany on May 15-16, 2023. With a focus on drug discovery for proteopathic ...
attyloid’s sFIDA Used in Detecting Parkinson’s-Related Biomarkers in Stool Samples
February 2, 2023A recent study published in Nature Parkinson’s Diease has used attyloid's sFIDA technology to measure α-synuclein aggregates in stool, a ...